Illinois 2023-2024 Regular Session

Illinois Senate Bill SB0647

Introduced
2/2/23  
Refer
2/2/23  
Refer
3/2/23  
Report Pass
3/9/23  
Refer
5/11/23  
Engrossed
4/10/24  
Refer
4/11/24  
Refer
4/15/24  
Report Pass
5/1/24  
Enrolled
5/24/24  
Chaptered
8/9/24  

Caption

HEALTH-TECH

Impact

The proposed changes are expected to significantly impact state laws by increasing accountability and transparency within mental health and substance use treatment systems. By requiring comprehensive reporting, the bill intends to ensure that facilities adhere to set standards of care, thereby improving the quality of services provided. Moreover, the enhanced regulations on controlled substances aim to mitigate the opioid crisis and reduce substance use disorders, especially among pregnant women and new mothers. This legislative move is pivotal in aligning Illinois with federal guidelines and improving healthcare delivery systems.

Summary

SB0647 focuses on amendments to the Mental Health and Developmental Disabilities Administrative Act and the Controlled Substances Act in Illinois. The bill seeks to enhance the oversight and reporting requirements for state-operated facilities that provide care for individuals with mental illnesses and developmental disabilities, specifically mandating quarterly electronic reports to the General Assembly about various metrics related to admissions and discharges. Additionally, it aims to strengthen regulations around the possession and dispensing of controlled substances by requiring strict compliance from health facilities and practitioners engaged in substance use treatment and research.

Sentiment

General sentiment around SB0647 appears supportive, particularly among mental health advocates who view these amendments as essential steps in addressing the state's ongoing challenges with mental health crises and substance abuse. Stakeholders appreciate the focus on maternal mental health, considering the documented impacts of untreated mental health conditions on mothers and their children. However, some concerns were voiced regarding the possible administrative burdens that increased reporting requirements could impose on state facilities, raising questions about resource allocation.

Contention

One notable point of contention surrounding the bill relates to the appropriateness of how stringent regulations should be applied to health facilities concerning controlled substances. While proponents argue that such measures are crucial for public health and safety, critics express concern over potential over-regulation that could hinder access to necessary treatments for patients suffering from substance use disorders. Additionally, ensuring effective training and support for healthcare workers to navigate these changes remains a significant discussion point among stakeholders.

Companion Bills

No companion bills found.

Previously Filed As

IL HB1242

MHDDAA-RN&MENTAL HLTH TECHS

IL HB2834

MHDD FACILTY-EMPLOYEE OVERTIME

IL SB0642

LOCAL GOVERNMENT-TECH

IL HB0686

LOCAL GOVERNMENT-TECH

IL SB2022

SAFE PATIENT LIMITS ACT

IL HB0609

HEALTH-TECH

IL HB0616

HEALTH-TECH

IL SB0010

HEALTH-TECH

IL SB0014

HEALTH-TECH

IL SB0607

HEALTH-TECH

Similar Bills

DE SCR39

Recognizing The Month Of March 2025 As Developmental Disabilities Awareness Month In The State Of Delaware.

CA AB1925

State permanent disability certification program: feasibility study.

HI SB850

Relating To Disability Health Disparity.

LA HB1092

Renames the office of citizens with developmental disabilities within the Louisiana Department of Health

CA AB2734

Vehicles: special interest license plates.

HI HB819

Relating To Disability Health Disparity.

HI HB819

Relating To Disability Health Disparity.

AZ HB2810

Developmental disabilities; Prader-Willi syndrome